Relative HPV Viral Load Measured by ΔCt for Risk Stratification in Cervical Cancer Screening
Open Access
Abstract
Background/Objectives: Human papillomavirus (HPV) testing is widely used in cervical cancer screening because of its high sensitivity, although its limited specificity requires effective triage strategies. This study aimed to evaluate the association between relative viral load (RVL) and cervical lesion severity, focusing on HPV-positive women with non-high-grade cytology. Methods: The study included 997 women with histological outcomes from a cohort of 2765 HPV-positive individuals identified among 37,030 women screened in the Bari metropolitan area (Italy) using a real-time HPV-DNA test. Associations between RVL, estimated using the ΔCt method, and lesion severity were assessed using histological and cytological classifications. Logistic regression models evaluated the independent effect of RVL, adjusting for age and HPV detection channel. Results: Lower ΔCt values (indicating higher RVL) were significantly associated with high-grade lesions (CIN2+) (OR = 0.91, 95% CI: 0.89–0.94, p < 0.001). The association was observed for HPV16 and the pooled 12-high-risk HPV detection channel, while no significant association was observed for HPV18. A similar association was observed when cytological classification was used as the outcome. Age showed a modest effect, with reduced odds of high-grade lesions observed in women aged ≥50 years. Among women with non-high-grade cytology who subsequently underwent histological assessment, 17.6% had underlying CIN2+, and RVL remained significantly associated with lesion severity in this subgroup. However, ΔCt showed only modest discrimination for high-grade lesions [AUC = 0.643 (95% CI: 0.605–0.681)]. Conclusions: Higher HPV RVL is associated with increased lesion severity, particularly for HPV16 and the pooled 12-high-risk detection channel, but not for HPV18. Given its modest standalone discriminatory performance and the selected nature of the histologically verified cohort, ΔCt should be considered an exploratory marker rather than a validated triage tool. Prospective validation is required to determine whether it provides incremental clinical value.Keywords
Funding Information
- Regione Liguria (23L03)
This publication has 31 references indexed in Scilit:
- Quality Assurance in Cervical Cancer Screening: Evaluation of Sample Adequacy in HPV DNA TestingJournal of Medical Virology, 2025
- Viral Load of Human Papillomavirus (HPV) During Pregnancy and Its Association With HPV Vertical TransmissionJournal of Medical Virology, 2025
- Correlation of different HPV genotype viral loads and cervical lesions: A retrospective analysis of 1585 casesCancer Cytopathology, 2024
- Increased human papillomavirus viral load is correlated to higher severity of cervical disease and poorer clinical outcome: A systematic reviewJournal of Medical Virology, 2024
- Risk stratification for cervical neoplasia using extended high‐risk HPV genotyping in women with ASC‐US cytology: A large retrospective study from ChinaCancer Cytopathology, 2021
- Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening ProgramJAMA Internal Medicine, 2019
- Type‐dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18International Journal of Cancer, 2017
- Association between human papillomavirus (HPV) 16, HPV18, and other HR‐HPV viral load and the histological classification of cervical lesions: Results from a large‐scale cross‐sectional studyJournal of Medical Virology, 2016
- Persistence and load of high‐risk HPV are predictors for development of high‐grade cervical lesions: A longitudinal French cohort studyInternational Journal of Cancer, 2003
- Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearanceInternational Journal of Cancer, 2002